Association of Inflammatory Markers FABP4, S100A12, BMP7, LCN2, and STAT5 With Cardiovascular Disease Risk in Rheumatoid Arthritis Patients: A Cross‐Sectional Study
Immunity, Inflammation and Disease · 2026-11 · 14 (11)
DOI: 10.1002/iid3.70607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 17.11.2026. Verfasst von Fatemeh Khoobbakht und 11 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kermanshah University of Medical Sciences.
Abstract (Originalsprache)
Background
Persistent systemic inflammation is a hallmark of rheumatoid arthritis (RA) and is closely associated with an increased burden of cardiovascular disease (CVD). Although several inflammatory biomarkers have individually been linked to RA and cardiovascular pathology, their simultaneous associations with conventional cardiovascular risk indicators in the same RA population remain incompletely characterized. This study aimed to investigate the associations between FABP4, S100A12, BMP7, LCN2, and STAT5 and established cardiovascular risk profiles in patients with RA compared with healthy controls.
Methods
This cross‐sectional study included 90 participants: 60 patients with RA (30 treatment‐naïve and 30 receiving treatment) and 30 healthy controls. Serum levels of FABP4, S100A12, and BMP7 were measured by ELISA, while mRNA expression of LCN2 and STAT5 was assessed using quantitative real‐time PCR. Associations between biomarkers and cardiovascular risk indicators, including Framingham Risk Score (FRS), Systematic Coronary Risk Evaluation (SCORE), high‐sensitivity C‐reactive protein (HS‐CRP), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), were evaluated using correlation and multivariable regression analyses adjusted for age, body mass index, disease activity, and lipid parameters. To reduce the likelihood of false‐positive findings, multiple comparisons were adjusted using the false discovery rate (FDR) approach.
Results
LCN2 expression was significantly elevated in both treatment‐naïve ( p = 0.011) and treated RA patients ( p = 0.003) compared with controls. FABP4 concentrations were significantly higher in treatment‐naïve patients (4.62 ± 0.61 ng/mL) than in treated patients (3.93 ± 0.87 ng/mL) and controls (3.30 ± 1.02 ng/mL). S100A12 levels were also increased in treatment‐naïve patients compared with controls, whereas BMP7 and STAT5 did not differ significantly among groups. FABP4 showed weak‐to‐moderate positive correlations with HS‐CRP, NT‐proBNP, FRS, and SCORE ( r ≈ 0.27–0.49). After FDR correction and multivariable adjustment, only selected associations remained statistically significant, particularly those involving FABP4 with NT‐proBNP and HS‐CRP and BMP7 with NT‐proBNP and DAS‐28.
Conclusion
In this single‐center cross‐sectional study, FABP4 and LCN2 showed associations with systemic inflammation and surrogate cardiovascular risk indicators in patients with RA. However, the observed associations were generally modest and should not be interpreted as evidence of causality, CVD progression, or predictive capability. Because cardiovascular risk was evaluated using surrogate risk scores rather than imaging modalities or clinical cardiovascular outcomes, the findings should be considered exploratory. Larger multicenter prospective studies are required to validate these observations and determine whether these biomarkers provide incremental value beyond established cardiovascular risk assessment tools.
Förderung
- Kermanshah University of Medical Sciences
Zitieren
APA
Khoobbakht, F., Roghani, S. A., Feizollahi, P., Soufivand, P., Assar, S., Pournazari, M., Rostampour, R., Shahrokhvand, S. Z., Bahrehmand, F., Salari, N., Taghadosi, M., & Shamsi, A. (2026). Association of Inflammatory Markers FABP4, S100A12, BMP7, LCN2, and STAT5 With Cardiovascular Disease Risk in Rheumatoid Arthritis Patients: A Cross‐Sectional Study. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70607
Vancouver
Khoobbakht F, Roghani SA, Feizollahi P, Soufivand P, Assar S, Pournazari M, et al. Association of Inflammatory Markers FABP4, S100A12, BMP7, LCN2, and STAT5 With Cardiovascular Disease Risk in Rheumatoid Arthritis Patients: A Cross‐Sectional Study. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70607
BibTeX
@article{Khoobbakht2026,
author = {Khoobbakht, Fatemeh and Roghani, Seyed Askar and Feizollahi, Parisa and Soufivand, Parviz and Assar, Shirin and Pournazari, Mehran and Rostampour, Rezvan and Shahrokhvand, Seyedeh Zahra and Bahrehmand, Fariborz and Salari, Nader and Taghadosi, Mahdi and Shamsi, Afsaneh},
title = {Association of Inflammatory Markers FABP4, S100A12, BMP7, LCN2, and STAT5 With Cardiovascular Disease Risk in Rheumatoid Arthritis Patients: A Cross‐Sectional Study},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/iid3.70607}
}
EUVIMED